Endeavor Clinical Trials the sole site selected to study the device prior to going to market.
CLICK HERE to read about the device and how it helps diabetics at risk of foot ulcers.
ECT was one of the sites that participated in studies investigating a non-opioid postoperative pain medicine. The sponsor, Heron Therapeutics, has announced positive topline results from its completed Phase 3 studies of the investigational agent HTX-011 in subjects undergoing bunionectomy and hernia repair, which achieved all primary and key secondary endpoints in both Phase 3 trials, demonstrating statistically significant reductions in both pain intensity and the use of opioid rescue medications through 72 hours following surgery.
CLICK HERE to read about the positive topline results from the Phase 3 clinical trial.
Endeavor Clinical Trials of San Antonio, Texas, has over 20 years of experience conducting research and clinical trials specializing in post-op pain, diabetic-related pain, other pain, diabetes, vaccines, dermatology and podiatry.
Richard A. Pollak, D.P.M., M.S., is a key opinion leader and board-certified by the American Board of Foot and Ankle Surgery. He has been practicing for over 35 years in San Antonio Texas, and is highly regarded for his participation in clinical and pharmaceutical research in the United States. He has been the Principal Investigator in more than 125 studies. He is an expert in multiple areas of podiatry including toenail fungus, athlete’s foot and diabetic foot ulcers.
The site is conveniently located 10 miles from the San Antonio International Airport. Endeavor has access to the highest quality patients and associated data. The site has a strong relationship with private practice physicians in San Antonio for patient referrals, which contributes to their strong recruitment performance. They are known for their exceptional safety preparedness, with all staff trained to BLS certification, ACLS certified personnel, PALS certified personnel, EMT-P staff and a crash cart on-site.
All data collected throughout the clinical trial goes through our stringent QA process ensuring data is clean and sponsor ready within 72 hours from time of collection.
Richard A. Pollak, D.P.M., M.S., is a key opinion leader and board-certified by the American Board of Foot and Ankle Surgery. He has been practicing for over 35 years in San Antonio Texas, and is highly regarded for his participation in clinical and pharmaceutical research in the United States. He has been the Principal Investigator in more than 125 studies. He is an expert in multiple areas of podiatry including toenail fungus, athlete’s foot and diabetic foot ulcers.
Dr. Pollak received his Doctor of Podiatric Medicine from the California College of Podiatric Medicine and later received his Master of Science degree from the Pennsylvania College of Podiatric Medicine. Dr. Pollak has authored and published many scientific articles, and he is a noted national lecturer. He is affiliated with Elegante Surgery Center, Foundation Surgical Hospital of San Antonio and CHRISTUS Santa Rosa Hospital Alamo Heights.